Vyvanse (lisdexamfetamine) is a prescription stimulant with two FDA-approved uses: treating attention deficit hyperactivity disorder (ADHD) in people aged 6 and older, and treating moderate to severe binge eating disorder (BED) in adults. It is a Schedule II controlled substance, meaning it has recognized medical value but also carries a high potential for abuse and dependence.
ADHD Treatment
ADHD is the primary reason Vyvanse is prescribed. It’s approved for children (starting at age 6), adolescents, and adults. For ADHD, Vyvanse works by increasing the activity of dopamine and norepinephrine in the brain, two chemical messengers that play central roles in attention, focus, and impulse control. In clinical studies, it improved attention starting about 1.5 hours after a dose in children aged 6 to 12, with effects lasting up to 13 hours. In adults, the window was similar: noticeable improvement at 2 hours, lasting up to 14 hours.
That long duration is one of the reasons Vyvanse is popular compared to shorter-acting stimulants. A single morning dose can cover an entire school or work day without needing a midday pill. The typical starting dose is 30 mg once daily, taken in the morning. From there, a prescriber can adjust upward in 10 or 20 mg steps each week, up to a maximum of 70 mg per day, depending on how well it controls symptoms and how you tolerate it.
Binge Eating Disorder Treatment
Vyvanse is the first and, as of now, only medication specifically FDA-approved for moderate to severe binge eating disorder in adults. BED involves recurring episodes of eating large amounts of food in a short period, accompanied by a feeling of loss of control and significant distress afterward. It’s distinct from bulimia because people with BED don’t regularly purge.
Vyvanse is not approved for weight loss. Its approval for BED is specifically about reducing the frequency of binge episodes. The starting dose mirrors ADHD treatment at 30 mg per day, but the target dose is higher: prescribers typically increase by 20 mg per week until reaching the recommended range of 50 to 70 mg daily. The maximum remains 70 mg per day.
How Vyvanse Works Differently From Other Stimulants
Vyvanse is a prodrug, which means the pill itself is inactive. After you swallow it, enzymes in your red blood cells gradually break down the lisdexamfetamine molecule into dextroamphetamine, the active compound that actually affects the brain. This conversion process is what gives Vyvanse its long, smooth duration of action. Because the drug depends on this enzymatic step in the bloodstream, the active ingredient enters the brain more gradually and at lower peak concentrations compared to taking dextroamphetamine directly.
This design also has implications for misuse. Crushing, snorting, or injecting Vyvanse doesn’t produce a faster or stronger effect the way it might with other stimulants, because the drug still needs to be processed by red blood cells regardless of how it enters the body. The pharmacological effects remain the same no matter the route of administration. That said, the DEA still classifies it as Schedule II, acknowledging that abuse and severe dependence remain possible.
Common Side Effects
The most frequently reported side effects overlap between the ADHD and BED uses. Decreased appetite is the most common, and it tends to be more noticeable in the first few weeks. Dry mouth, trouble sleeping (especially if the dose is taken too late in the day), and increased heart rate are also typical. Some people experience irritability, anxiety, or nausea, particularly during dose adjustments.
Because Vyvanse is a stimulant, it can raise blood pressure and heart rate. People with pre-existing heart conditions are generally evaluated more carefully before starting treatment. In children and adolescents, long-term use has been associated with slight reductions in expected growth, so prescribers often monitor height and weight over time.
Off-Label Uses
Beyond its two approved indications, stimulants as a class (including Vyvanse) are sometimes prescribed off-label for other conditions. The evidence behind these uses varies widely and is generally much weaker than for ADHD or BED.
- Treatment-resistant depression: Some clinicians prescribe stimulants as an add-on when standard antidepressants haven’t worked, particularly in older adults. The supporting evidence is modest, and no strong consensus exists for this use.
- Cognitive difficulties after traumatic brain injury: There is limited research suggesting stimulants may help with focus and processing speed after a mild to moderate brain injury, but no definitive recommendations support routine use.
- Fatigue in neurological conditions: Stimulants have been tried for fatigue related to multiple sclerosis and other neurological disorders. A 2021 study in The Lancet Neurology compared several fatigue medications to placebo and found no meaningful difference between any of them, suggesting the benefits may be largely placebo-driven.
- Excessive daytime sleepiness: While other medications are specifically approved for this, stimulants are occasionally used off-label when first-line options are insufficient.
These off-label uses highlight that while stimulants have broad effects on alertness and cognition, the clinical evidence outside of ADHD and BED is thin. If a prescriber recommends Vyvanse for something other than its approved uses, it’s reasonable to ask about the strength of evidence for that specific situation.
What to Expect When Starting Vyvanse
Most people begin at 30 mg and increase gradually over several weeks. The goal is to find the lowest dose that adequately controls symptoms without bothersome side effects. Because the drug lasts up to 14 hours, timing matters. Taking it too late in the morning (or certainly in the afternoon) can interfere with sleep. Most prescribers recommend taking it first thing in the morning, with or without food.
You’ll likely notice effects within the first day or two, but finding the right dose can take a few weeks of adjustments. Appetite suppression tends to be strongest in the first month and may lessen over time. Some people find it helpful to eat a solid breakfast before the medication kicks in and to plan a larger evening meal when appetite returns.
Because Vyvanse is a Schedule II controlled substance, prescriptions come with tighter regulations than most medications. In many states, refills require a new prescription each month, and early refills are restricted. Your prescriber may require periodic check-ins to monitor how the medication is working and to screen for any signs of misuse or cardiovascular changes.